arginine salt stabilized bpc-157 Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway Pentadeca Arginate vs BPC-157: Benefits
Description
These injections are contra-indicated for patients with Optic Nerve Atrophy, Hemachromatosis, and Lebers Disease

Start at 0.1-0.25 mg , not 0.5 mg

Store correctly: Once reconstituted, keep in the fridge (28 C)

BPC-157 TB-500
